These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30172061)

  • 1. Phenotypic Characterization of Paclitaxel-Induced Peripheral Neuropathy in Cancer Survivors.
    Kober KM; Mazor M; Abrams G; Olshen A; Conley YP; Hammer M; Schumacher M; Chesney M; Smoot B; Mastick J; Paul SM; Levine JD; Miaskowski C
    J Pain Symptom Manage; 2018 Dec; 56(6):908-919.e3. PubMed ID: 30172061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of mitochondrial dysfunction-related genes and pathways in paclitaxel-induced peripheral neuropathy in breast cancer survivors.
    Kober KM; Olshen A; Conley YP; Schumacher M; Topp K; Smoot B; Mazor M; Chesney M; Hammer M; Paul SM; Levine JD; Miaskowski C
    Mol Pain; 2018; 14():1744806918816462. PubMed ID: 30426838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen decline is a risk factor for paclitaxel-induced peripheral neuropathy: Clinical evidence supported by a preclinical study.
    Miyamoto T; Hiramoto S; Kanto A; Tsubota M; Fujitani M; Fukuyama H; Hatanaka S; Sekiguchi F; Koizumi Y; Kawabata A
    J Pharmacol Sci; 2021 May; 146(1):49-57. PubMed ID: 33858655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perturbations in neuroinflammatory pathways are associated with paclitaxel-induced peripheral neuropathy in breast cancer survivors.
    Miaskowski C; Topp K; Conley YP; Paul SM; Melisko M; Schumacher M; Chesney M; Abrams G; Levine JD; Kober KM
    J Neuroimmunol; 2019 Oct; 335():577019. PubMed ID: 31401418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for paclitaxel-induced peripheral neuropathy in patients with breast cancer.
    Ghoreishi Z; Keshavarz S; Asghari Jafarabadi M; Fathifar Z; Goodman KA; Esfahani A
    BMC Cancer; 2018 Oct; 18(1):958. PubMed ID: 30290775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of chemotherapy-induced neurotoxicities on adult cancer survivors' symptom burden and quality of life.
    Miaskowski C; Mastick J; Paul SM; Abrams G; Cheung S; Sabes JH; Kober KM; Schumacher M; Conley YP; Topp K; Smoot B; Mausisa G; Mazor M; Wallhagen M; Levine JD
    J Cancer Surviv; 2018 Apr; 12(2):234-245. PubMed ID: 29159795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential methylation and expression of genes in the hypoxia-inducible factor 1 signaling pathway are associated with paclitaxel-induced peripheral neuropathy in breast cancer survivors and with preclinical models of chemotherapy-induced neuropathic pain.
    Kober KM; Lee MC; Olshen A; Conley YP; Sirota M; Keiser M; Hammer MJ; Abrams G; Schumacher M; Levine JD; Miaskowski C
    Mol Pain; 2020; 16():1744806920936502. PubMed ID: 32586194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the effect of N-acetylcysteine on the prevention and amelioration of paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled study.
    Khalefa HG; Shawki MA; Aboelhassan R; El Wakeel LM
    Breast Cancer Res Treat; 2020 Aug; 183(1):117-125. PubMed ID: 32601973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel-induced sensory peripheral neuropathy is associated with an ABCB1 single nucleotide polymorphism and older age in Japanese.
    Tanabe Y; Shimizu C; Hamada A; Hashimoto K; Ikeda K; Nishizawa D; Hasegawa J; Shimomura A; Ozaki Y; Tamura N; Yamamoto H; Yunokawa M; Yonemori K; Takano T; Kawabata H; Tamura K; Fujiwara Y
    Cancer Chemother Pharmacol; 2017 Jun; 79(6):1179-1186. PubMed ID: 28447211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy-Induced Neuropathy in Cancer Survivors.
    Miaskowski C; Mastick J; Paul SM; Topp K; Smoot B; Abrams G; Chen LM; Kober KM; Conley YP; Chesney M; Bolla K; Mausisa G; Mazor M; Wong M; Schumacher M; Levine JD
    J Pain Symptom Manage; 2017 Aug; 54(2):204-218.e2. PubMed ID: 28063866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: A retrospective study in Japan.
    Hiramoto S; Asano H; Miyamoto T; Takegami M; Kawabata A
    PLoS One; 2021; 16(12):e0261473. PubMed ID: 34972132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of KCNQ Channels Prevents Paclitaxel-Induced Peripheral Neuropathy and Associated Neuropathic Pain.
    Li L; Li J; Zuo Y; Dang D; Frost JA; Yang Q
    J Pain; 2019 May; 20(5):528-539. PubMed ID: 30471428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hearing loss and tinnitus in survivors with chemotherapy-induced neuropathy.
    Miaskowski C; Paul SM; Mastick J; Schumacher M; Conley YP; Smoot B; Abrams G; Kober KM; Cheung S; Henderson-Sabes J; Chesney M; Mazor M; Wallhagen M; Levine JD
    Eur J Oncol Nurs; 2018 Feb; 32():1-11. PubMed ID: 29353626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical and Clinical Evidence of Therapeutic Agents for Paclitaxel-Induced Peripheral Neuropathy.
    Kawashiri T; Inoue M; Mori K; Kobayashi D; Mine K; Ushio S; Kudamatsu H; Uchida M; Egashira N; Shimazoe T
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of paclitaxel-induced peripheral neuropathy in patients using clopidogrel: a retrospective pilot study.
    Matsuo M; Ito H; Takemura Y; Hattori M; Kawakami M; Takahashi N; Yamazaki M
    J Anesth; 2017 Aug; 31(4):631-635. PubMed ID: 28451807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer.
    Tanabe Y; Hashimoto K; Shimizu C; Hirakawa A; Harano K; Yunokawa M; Yonemori K; Katsumata N; Tamura K; Ando M; Kinoshita T; Fujiwara Y
    Int J Clin Oncol; 2013 Feb; 18(1):132-8. PubMed ID: 22105895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed recovery and increased severity of Paclitaxel-induced peripheral neuropathy in patients with diabetes.
    de la Morena Barrio P; Conesa MÁ; González-Billalabeitia E; Urrego E; García-Garre E; García-Martínez E; Poves MZ; Vicente V; de la Peña FA
    J Natl Compr Canc Netw; 2015 Apr; 13(4):417-23. PubMed ID: 25870378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: a randomized double-blind placebo controlled trial.
    Ghoreishi Z; Esfahani A; Djazayeri A; Djalali M; Golestan B; Ayromlou H; Hashemzade S; Asghari Jafarabadi M; Montazeri V; Keshavarz SA; Darabi M
    BMC Cancer; 2012 Aug; 12():355. PubMed ID: 22894640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desloratadine ameliorates paclitaxel-induced peripheral neuropathy and hypersensitivity reactions in mice.
    Lu J; Zhao XJ; Ruan Y; Liu XJ; Di X; Xu R; Wang JY; Qian MY; Jin HM; Li WJ; Shen X
    Acta Pharmacol Sin; 2024 Oct; 45(10):2061-2076. PubMed ID: 38789495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical identification of predictors for paclitaxel-induced peripheral neuropathy in patients with breast or gynaecological cancer.
    Kanbayashi Y; Hosokawa T; Kitawaki J; Taguchi T
    Anticancer Res; 2013 Mar; 33(3):1153-6. PubMed ID: 23482795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.